


Chengdu Pukang Biotechnology Revenue
Pharmaceutical Manufacturing • Wenjiang District, Sichuan, China • 1-10 Employees
Chengdu Pukang Biotechnology revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Key Contact at Chengdu Pukang Biotechnology
Benjamin Neuhaus
Bd & Sales Director - Overseas Business
Company overview
| Headquarters | Room 1-9,Building7,No.288 of North Rongtai Avenue,WenJiang district 611137,Chengdu Sichuan Province,China., Chengdu, Chengdu 610000, CN |
| Phone number | +8613708084407 |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Keywords | Liraglutide Side Chain, Tirzepatide Side Chain, Peptide Sidechains As Well As Fragments, Semaglutide Side Chain, Short Peptide, Small Molecular Peg Derivatives |
| Founded | 2008 |
| Employees | 1-10 |
| Socials |
Chengdu Pukang Biotechnology Email Formats
Chengdu Pukang Biotechnology uses 3 email formats. The most common is {first name} (e.g., john@pu-kang.com), used 62.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@pu-kang.com | 62.5% |
{first initial} | j@pu-kang.com | 25% |
{first initial}.{last name} | j.doe@pu-kang.com | 12.5% |
About Chengdu Pukang Biotechnology
Chengdu Pukang Biotechnology Technology Co., Ltd. was established in 2008. For more than ten years, it has been focusing on the research and development, production and sales of polypeptide modify side chains and single-molecule PEG (referred to as small molecule PEG) derivatives , has built small molecule PEG derivatives block library. Pukang has built a polypeptide long-acting modifier platform, which can not only provide hundreds of different types of peptide long-acting side chain molecules, but also provide high-quality long-acting side chain design services, quality research and CDE documents; Long-acting side chains can be used for GLP-1, GCP and anti-HIV drugs to improve half-life and enhance patient compliance. We have a 3,000-square-meter R&D a 2,000-square-meter pilot-scale laboratory and a 60,000-square-meter production base that meets GMP requirements.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Chengdu Pukang Biotechnology has 5 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



